DRDGOLD DRD Q3 Fiscal 2014 Earnings NarrowerThanExpected Loss Highlights Operational Discipline LIXT Q4 2024 Earnings ClinicalStage Biotech Reports perShare Loss as Development Continues EGO Q1 2026 Earnings Stellar EPS Beat Drives Investor Caution Despite Strong Operational Performance CTO Q1 2026 Earnings Massive EPS Surprise of 374 as FFO Exceeds Expectations LZ Q1 2026 Earnings EPS Misses Estimates Stock Declines 14 UFCS Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Strong Performance